* Inogen Inc INGN.OQ INGN.O is expected to show a fall
in
quarterly revenue when it reports results
* The Goleta California-based company is expected to report
a
21.8% decrease in revenue to $82.463 million from $105.39
million a year ago, according to the mean estimate from 3
analysts, based on LSEG data.
* Refinitiv's mean analyst estimate for Inogen Inc is for a
loss
of 49 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Inogen Inc
is
$8, above its last closing price of $5.33.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.61 -0.59 -0.42 Beat 29.3
Mar. 31 2023 -0.82 -0.78 -0.88 Missed -12.8
Dec. 31 2022 -0.56 -0.57 -0.20 Beat 65.2
Sep. 30 2022 -0.42 -0.42 -0.42 Met -0.2
Jun. -0.37 -0.37 -0.15 Beat 59.5
30 2022
Mar. 31 2022 -0.52 -0.51 -0.62 Missed -21.8
Dec. 31 2021 -0.72 -0.73 -1.01 Missed -38.6
Sep. 30 2021 -0.31 -0.26 0.53 Beat 303.8
This summary was machine generated November 4 at 03:05 GMT. All
figures in US dollars unless otherwise stated